Ad is loading...
MVGAX
Price
$18.25
Change
+$0.08 (+0.44%)
Updated
Nov 22 closing price
RWBEX
Price
$67.86
Change
+$0.23 (+0.34%)
Updated
Nov 22 closing price
Ad is loading...

MVGAX vs RWBEX

Header iconMVGAX vs RWBEX Comparison
Open Charts MVGAX vs RWBEXBanner chart's image
MFS Low Volatility Global Equity A
Price$18.25
Change+$0.08 (+0.44%)
VolumeN/A
CapitalizationN/A
American Funds Capital World Gr&Inc R2E
Price$67.86
Change+$0.23 (+0.34%)
VolumeN/A
CapitalizationN/A
MVGAX vs RWBEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MVGAX vs. RWBEX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MVGAX is a StrongBuy and RWBEX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RWBEX has more cash in the bank: 126B vs. MVGAX (275M). RWBEX pays higher dividends than MVGAX: RWBEX (1.28) vs MVGAX (1.10). MVGAX was incepted earlier than RWBEX: MVGAX (11 years) vs RWBEX (10 years). RWBEX is a more actively managed with annual turnover of: 27.00 vs. MVGAX (25.00). RWBEX has a lower initial minimum investment than MVGAX: RWBEX (250) vs MVGAX (1000). MVGAX annual gain was more profitable for investors over the last year : 20.17 vs. RWBEX (18.29). RWBEX return over 5 years is better than : 39.09 vs. MVGAX (34.48).
MVGAXRWBEXMVGAX / RWBEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years10 years-
Gain YTD16.07613.870116%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets275M126B0%
Annual Yield % from dividends1.101.2886%
Returns for 1 year20.1718.29110%
Returns for 3 years9.395.19181%
Returns for 5 years34.4839.0988%
Returns for 10 years79.9947.47168%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYOFX15.580.37
+2.43%
Royce Small-Cap Opportunity Svc
ACGQX24.610.25
+1.03%
Invesco Growth and Income R5
MEFIX12.790.04
+0.31%
Martin Currie Emerging Markets FI
MSEEX21.100.03
+0.14%
Morgan Stanley Europe Opportunity C
MDNAF1.06N/A
-0.33%
Medicenna Therapeutics Corp.